{
  "url": "https://openlegislation.uk/eu-regulation-2017-644/annex-III/division-8/division-2",
  "json_url": "https://openlegislation.uk/eu-regulation-2017-644/annex-III/division-8/division-2.json",
  "legislation": "eur/2017/644",
  "legislation_title": "Commission Regulation (EU) 2017/644 of 5 April 2017 laying down methods of sampling and analysis for the control of levels of dioxins, dioxin-like PCBs and non-dioxin-like PCBs in certain foodstuffs and repealing Regulation (EU) No 589/2014 (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2017-644",
  "path": "annex/III/division/8/division/2",
  "kind": "division",
  "number": null,
  "heading": "Bioanalytical screening methods",
  "text": "The result of the screening shall be expressed as compliant or suspected to be non-compliant (‘suspected’).\nIn addition, an indicative result for PCDD/F and/or dioxin-like PCBs expressed in BEQ (not TEQ) may be given (see point 1). Samples with a response below the reporting limit shall be expressed as lower than the reporting limit. Samples with a response above the working range shall be reported as exceeding the working range and the level corresponding to the upper end of the working range shall be given in BEQ.\nFor each type of sample matrix, the report shall mention the maximum or action level on which the evaluation is based.\nThe report shall mention the type of test applied, the basic test principle and kind of calibration.\nThe report shall also include the method used for extraction of PCDD/Fs, dioxin-like PCBs and lipids. The lipid content of the sample shall be determined and reported for food matrices with maximum levels expressed on fat basis and with an expected fat concentration in the range of 0-2 % (in correspondence to existing legislation). For other samples, the determination of the lipid content is optional.\nIn the case of samples suspected to be non-compliant, the report needs to include a note on the action to be taken. The concentration of PCDD/Fs and the sum of PCDD/Fs and dioxin-like PCBs in those samples with elevated levels has to be determined/confirmed by a confirmatory method.\nNon-compliant results shall only be reported from confirmatory analysis.",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2017/644/annex/III/division/8/division/2",
    "retrieved_at": "2026-11-01T14:45:03.439389+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}